Dizal Pharmaceutical Co (SHSE:688192) Institutional Ownership: 17.71% (As of Aug. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688192 Dizal Pharmaceutical Co Ltd SHSE:688192
41 GF Score
Price ¥59.00
GF Value ¥129.35
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Dizal Pharmaceutical Co Institutional Ownership?

Dizal Pharmaceutical Co SHSE:688192 -5.07% 41 Institutional Ownership is 17.71% as of Aug. 23, 2026. GuruFocus rates SHSE:688192 with a GF Score™ of 41/100 and a GF Value™ of ¥129.35 (Possible Value Trap). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Dizal Pharmaceutical Co's institutional ownership is 17.71%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Dizal Pharmaceutical Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Dizal Pharmaceutical Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Dizal Pharmaceutical Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Dizal Pharmaceutical Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dizal Pharmaceutical Co Institutional Ownership Chart

Dizal Pharmaceutical Co Historical Data

The historical data trend for Dizal Pharmaceutical Co can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 18.82 18.94 17.62 17.51 17.49 17.48 17.46 17.54 17.55 17.71
SHSE:688192
41GF Score
Dizal Pharmaceutical Co Ltd SHSE:688192
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dizal Pharmaceutical Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 17.71% mean?
Dizal Pharmaceutical Co (SHSE:688192) has a Institutional Ownership of 17.71% as of Aug. 23, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Dizal Pharmaceutical Co and its competitors.
Is Dizal Pharmaceutical Co's Institutional Ownership too high?
Dizal Pharmaceutical Co's current Institutional Ownership is 17.71%. Overall, Dizal Pharmaceutical Co has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dizal Pharmaceutical Co's Institutional Ownership compare to ZTS?
Dizal Pharmaceutical Co's Institutional Ownership of 17.71% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Dizal Pharmaceutical Co and its competitors. Dizal Pharmaceutical Co's current Institutional Ownership is 17.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dizal Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Dizal Pharmaceutical Co (SHSE:688192) is currently considered Possible Value Trap. The stock's GF Value™ is ¥129.35, compared to a current price of ¥59.00 — trading 54.4% below its estimated fair value. The current Institutional Ownership is 17.71%. Dizal Pharmaceutical Co's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Dizal Pharmaceutical Co (SHSE:688192), the current Institutional Ownership is 17.71% as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dizal Pharmaceutical Co (SHSE:688192) Overvalued in 2026?

Based on GuruFocus' analysis, Dizal Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥59.00 is trading 54.4% below its estimated GF Value™ of ¥129.35. GuruFocus considers Dizal Pharmaceutical Co to be Possible Value Trap.

Key valuation signals for SHSE:688192:

  • Institutional Ownership: 17.71%
  • GF Value™: ¥129.35 vs. price of ¥59.00 (54.4% below fair value)
  • GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688192 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dizal Pharmaceutical Co Business Description

Address Jinghui East Road, Room 4105, Building E (Building 5), Huirong Business Plaza, Xinwu District, Jiangsu Province, Wuxi City, CHN, 201203
Dizal Pharmaceutical Co Ltd, formerly Dizal (Jiangsu) Pharmaceutical Co Ltd is engaged in the research and development, production and sales of innovative drugs.
41GF Score

Get the complete analysis for SHSE:688192

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥59.00
Price
¥129.35
GF Value